Literature DB >> 22252646

Vecuronium was safely used in a patient with Engelmann's disease without muscle weakness.

Koji Sato, Maiko Nakajima, Tetsu Kimura, Toshiaki Nishikawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252646     DOI: 10.1007/s00540-011-1319-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  4 in total

1.  Anaesthesia in Engelmann's disease.

Authors:  J Mason; I Slee
Journal:  Anaesthesia       Date:  1968-04       Impact factor: 6.955

2.  Muscle involvement in progressive diaphyseal dysplasia.

Authors:  Y Naveh; R Ludatshcer; U Alon; B Sharf
Journal:  Pediatrics       Date:  1985-12       Impact factor: 7.124

3.  Muscular changes in Engelmann's disease.

Authors:  H Yoshioka; M Mino; N Kiyosawa; Y Hirasawa; Y Morikawa; Y Kasubuchi; T Kusunoki
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

4.  Camurati-Engelmann disease. Review of radioclinical features.

Authors:  F M Vanhoenacker; K Janssens; W Van Hul; R Gershoni-Baruch; R Brik; A M De Schepper
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.